Adicet Bio Inc (ACET)
1.31
+0.05
(+3.97%)
USD |
NASDAQ |
Nov 05, 16:00
1.31
0.00 (0.00%)
After-Hours: 18:21
Adicet Bio Max Drawdown (5Y): 98.67% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 98.67% |
| September 30, 2024 | 98.67% |
| August 31, 2024 | 98.67% |
| July 31, 2024 | 98.67% |
| June 30, 2024 | 98.67% |
| May 31, 2024 | 98.67% |
| April 30, 2024 | 98.67% |
| March 31, 2024 | 98.67% |
| February 29, 2024 | 98.67% |
| January 31, 2024 | 98.67% |
| December 31, 2023 | 98.67% |
| November 30, 2023 | 98.67% |
| October 31, 2023 | 98.67% |
| September 30, 2023 | 98.54% |
| August 31, 2023 | 98.23% |
| July 31, 2023 | 98.07% |
| June 30, 2023 | 98.07% |
| May 31, 2023 | 95.81% |
| April 30, 2023 | 95.81% |
| March 31, 2023 | 95.81% |
| February 28, 2023 | 95.81% |
| January 31, 2023 | 95.81% |
| December 31, 2022 | 95.81% |
| November 30, 2022 | 95.81% |
| October 31, 2022 | 95.81% |
| Date | Value |
|---|---|
| September 30, 2022 | 95.81% |
| August 31, 2022 | 95.81% |
| July 31, 2022 | 95.81% |
| June 30, 2022 | 95.81% |
| May 31, 2022 | 95.81% |
| April 30, 2022 | 95.81% |
| March 31, 2022 | 95.81% |
| February 28, 2022 | 95.81% |
| January 31, 2022 | 95.81% |
| December 31, 2021 | 95.81% |
| November 30, 2021 | 95.81% |
| October 31, 2021 | 95.81% |
| September 30, 2021 | 95.81% |
| August 31, 2021 | 95.81% |
| July 31, 2021 | 95.81% |
| June 30, 2021 | 95.81% |
| May 31, 2021 | 95.81% |
| April 30, 2021 | 95.81% |
| March 31, 2021 | 95.81% |
| February 28, 2021 | 95.81% |
| January 31, 2021 | 95.81% |
| December 31, 2020 | 95.81% |
| November 30, 2020 | 95.81% |
| October 31, 2020 | 95.81% |
| September 30, 2020 | 95.81% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
94.87%
Minimum
Nov 2019
98.67%
Maximum
Oct 2023
96.53%
Average
95.81%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| CEL-SCI Corp | 96.78% |
| AIM ImmunoTech Inc | 99.61% |
| IGC Pharma Inc | 97.77% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Protalix BioTherapeutics Inc | 94.35% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -77.80 |
| Beta (5Y) | 1.808 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 92.13% |
| Historical Sharpe Ratio (5Y) | -0.5911 |
| Historical Sortino (5Y) | -1.234 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.34% |